| Dr Gregory Louis Roesel, MD | |
|
915 Gordon Ave, Thomasville, GA 31792-6614 | |
| (229) 228-2000 | |
| Not Available |
| Full Name | Dr Gregory Louis Roesel |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 915 Gordon Ave, Thomasville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871546655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 055880 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John D Archbold Memorial Hospital | Thomasville, GA | Hospital |
| Grady General Hospital | Cairo, GA | Hospital |
| Brooks County Hospital | Quitman, GA | Hospital |
| Mitchell County Hospital | Camilla, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brooks County Hospital | 1557279049 | 16 |
| John D. Archbold Memorial Hospital, Inc. | 4981502622 | 62 |
| Hospital Authority Of Mitchell County | 6002724598 | 31 |
| Grady General Hospital | 7618866518 | 29 |
News Archive
Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
› Verified 6 days ago
| Entity Name | Hospital Authority Of Mitchell County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700830247 PECOS PAC ID: 6002724598 Enrollment ID: O20031117000138 |
News Archive
Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
› Verified 6 days ago
| Entity Name | John D. Archbold Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194779702 PECOS PAC ID: 4981502622 Enrollment ID: O20031219000506 |
News Archive
Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
› Verified 6 days ago
| Entity Name | Grady General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013961507 PECOS PAC ID: 7618866518 Enrollment ID: O20040310001254 |
News Archive
Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
› Verified 6 days ago
| Entity Name | Brooks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306890942 PECOS PAC ID: 1557279049 Enrollment ID: O20040316000884 |
News Archive
Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Louis Roesel, MD 920 Cairo Rd, Thomasville, GA 31792-4255 Ph: (229) 228-8800 | Dr Gregory Louis Roesel, MD 915 Gordon Ave, Thomasville, GA 31792-6614 Ph: (229) 228-2000 |
News Archive
Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
› Verified 6 days ago
Kelley Stafford Helquist, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 714 N Dawson St, Thomasville, GA 31792 Phone: 904-252-7761 | |
Jerry Steven Johnson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 116 Mimosa Dr, Thomasville, GA 31792 Phone: 229-228-2982 Fax: 229-551-8784 | |
Dr. Kathleen Lee Hannan, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 915 Gordon Ave, Thomasville, GA 31792 Phone: 229-228-2000 | |
Dr. Eduardo Jose Stincer, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 915 Gordon Ave, Thomasville, GA 31792 Phone: 229-228-2000 | |
Dr. Sharif Darwish, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 915 Gordon Ave, Thomasville, GA 31792 Phone: 229-228-2000 | |
Dr. David Andrew Saunders, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 116 Mimosa Dr, Thomasville, GA 31792 Phone: 229-228-2982 Fax: 229-551-8784 | |
Dr. Cary Carter Newman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 915 Gordon Ave, Thomasville, GA 31792 Phone: 229-228-2000 |